Treatment outcome of 301 aplastic anemia patients in China: a 10-year follow-up and real-world data from single institute experience-Reference-Cited by-同舟云学术

Treatment outcome of 301 aplastic anemia patients in China: a 10-year follow-up and real-world data from single institute experience

Published:2021-01-01 Issue:1 Volume:26 Page:1025-1030
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Zhang Xiao-tian¹,Wang Xue¹,Cao Jiang¹,Chen Wei¹,Qi Kun-ming¹,Qi Na¹,Liang Fei¹,Dong Xue-yan¹,Tang Guo-feng¹,Li De-peng¹,Sang Wei¹^ORCID,Li Zhen-yu¹,Cheng Hai¹,Xu Kai-lin¹²³

Affiliation:

1. Department of Hematology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, People’s Republic of China

2. Institute of Hematology, Xuzhou Medical University, Xuzhou, People’s Republic of China

3. Key Laboratory of Bone Marrow Stem Cell, Xuzhou, People’s Republic of China

Funder

Young Medical Key Talents Foundation of Jiangsu Province

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2021.2009646

Reference28 articles.

1. Current concepts in the pathophysiology and treatment of aplastic anemia

2. Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without Cyclosporine

3. TREATMENT OF APLASTIC ANÆMIA BY ANTILYMPHOCYTE GLOBULIN WITH AND WITHOUT ALLOGENEIC BONE-MARROW INFUSIONS

4. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients

5. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomogram establishment for short-term survival prediction in ICU patients with aplastic anemia based on the MIMIC-IV database;Hematology;2024-04-16

2. Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory/relapsed/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial;Annals of Medicine;2023-06-15

3. 2-DG Re-Normalized IFN-γ Production in T Cells Excluding T_EMRA Cells from Patients with Aplastic Anemia;Immunological Investigations;2023-03-29

4. Increased IFN‐γ⁺ and TNF‐α⁺ mucosal‐associated invariant T cells in patients with aplastic anemia;Cytometry Part B: Clinical Cytometry;2023-02-13